On top of its potential as a possible therapeutic target, the circulating level of ADAM10 and/or its substrates may be useful as a diagnostic as well as prognostic biomarker for cardiovascular disease, Alzheimer disease, and cancer.12 Here, ADAM10 is linked to early-onset autosomal dominant Alzheimer disease.